Vivo Ventures V LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-06-11 5:00 pm Sale | 2020-06-09 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Ventures V LLC | 55,742 1.800% | -146,150 (-72.39%) | Filing |